Bell Investment Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.99K | Hold |
83
| – | – | ﹤0.01% | 1199 |
|
2025
Q1 | $3.27K | Sell |
83
-8
| -9% | -$315 | ﹤0.01% | 1105 |
|
2024
Q4 | $2.74K | Buy |
91
+32
| +54% | +$964 | ﹤0.01% | 1208 |
|
2024
Q3 | $1.38K | Sell |
59
-62
| -51% | -$1.45K | ﹤0.01% | 1489 |
|
2024
Q2 | $2.15K | Buy |
121
+34
| +39% | +$605 | ﹤0.01% | 1320 |
|
2024
Q1 | $1.32K | Hold |
87
| – | – | ﹤0.01% | 1510 |
|
2023
Q4 | $1.49K | Hold |
87
| – | – | ﹤0.01% | 1450 |
|
2023
Q3 | $728 | Hold |
87
| – | – | ﹤0.01% | 1661 |
|
2023
Q2 | $2.16K | Hold |
87
| – | – | ﹤0.01% | 1256 |
|
2023
Q1 | $1.31K | Hold |
87
| – | – | ﹤0.01% | 1457 |
|
2022
Q4 | $1.03K | Buy |
+87
| New | +$1.03K | ﹤0.01% | 1576 |
|
2021
Q4 | – | Sell |
-52
| Closed | -$2K | – | 1942 |
|
2021
Q3 | $2K | Buy |
+52
| New | +$2K | ﹤0.01% | 1161 |
|